$4.46 Billion is the total value of Granahan Investment Management's 192 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 22.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ENPH | Sell | ENPHASE ENERGY | $235,658,000 | +86.5% | 1,343,010 | -12.2% | 5.29% | +23.3% |
| MGNI | Sell | MAGNITE INC | $206,222,000 | +196.3% | 6,715,157 | -33.0% | 4.63% | +95.9% |
| AXON | Sell | AXON ENTERPRISE | $134,598,000 | +30.7% | 1,098,491 | -3.3% | 3.02% | -13.6% |
| EHTH | Sell | EHEALTH INC | $51,673,000 | -20.1% | 731,807 | -10.6% | 1.16% | -47.1% |
| VCEL | Sell | VERICEL CORPORATION | $33,716,000 | +41.6% | 1,091,836 | -15.1% | 0.76% | -6.3% |
| ZS | Sell | ZSCALER INC | $30,224,000 | +40.0% | 151,338 | -1.4% | 0.68% | -7.5% |
| EVER | Sell | EVERQUOTE INC | $27,605,000 | -18.1% | 739,092 | -15.3% | 0.62% | -45.8% |
| VCYT | Sell | VERACYTE INC | $26,482,000 | +10.8% | 541,113 | -26.4% | 0.59% | -26.8% |
| NEO | Sell | NEOGENOMICS | $24,860,000 | +18.5% | 461,740 | -18.8% | 0.56% | -21.6% |
| CNMD | Sell | CONMED CORP | $23,711,000 | +17.9% | 211,707 | -17.2% | 0.53% | -22.0% |
| SSTI | Sell | SHOTSPOTTER | $23,170,000 | +19.2% | 614,589 | -1.8% | 0.52% | -21.1% |
| CSII | Sell | CARDIOVASCULAR SYSTEMS | $20,783,000 | -6.0% | 474,938 | -15.4% | 0.47% | -37.9% |
| IIPR | Sell | INNOVATIVE INDUSTRIAL PRODUCTSreit | $16,920,000 | +25.3% | 92,393 | -15.1% | 0.38% | -17.0% |
| CYRX | Sell | CRYOPORT | $16,255,000 | -25.1% | 370,443 | -19.1% | 0.36% | -50.5% |
| CSTL | Sell | CASTLE BIOSCIENCES | $15,242,000 | -19.5% | 226,988 | -38.3% | 0.34% | -46.7% |
| ALTG | Sell | ALTA EQUIPMENT GROUP INC | $15,206,000 | +12.5% | 1,539,019 | -10.8% | 0.34% | -25.5% |
| LMND | Sell | LEMONADE INC | $14,969,000 | +100.5% | 122,199 | -18.6% | 0.34% | +32.8% |
| PCRX | Sell | PACIRA BIOSCIENCES INC | $13,764,000 | -7.2% | 230,011 | -6.8% | 0.31% | -38.6% |
| FLXN | Sell | FLEXION THERAPEUTICS INC | $13,764,000 | +5.1% | 1,192,748 | -5.2% | 0.31% | -30.4% |
| MTRN | Sell | MATERION CORPORATION | $12,738,000 | +5.3% | 199,899 | -14.0% | 0.29% | -30.4% |
| TITN | Sell | TITAN MACHINERY | $12,328,000 | +25.7% | 630,606 | -14.9% | 0.28% | -16.8% |
| ROLL | Sell | RBC BEARINGS | $12,089,000 | +6.6% | 67,523 | -27.8% | 0.27% | -29.6% |
| ESPR | Sell | ESPERION THERAPEUTICS | $11,710,000 | -35.5% | 450,398 | -7.7% | 0.26% | -57.3% |
| INSM | Sell | INSMED | $11,584,000 | -13.1% | 347,981 | -16.1% | 0.26% | -42.5% |
| BPMC | Sell | BLUEPRINT MEDICINES CORPORATIO | $10,966,000 | -8.0% | 97,782 | -23.9% | 0.25% | -39.1% |
| EDIT | Sell | EDITAS MEDICINE | $10,881,000 | +111.6% | 155,202 | -15.3% | 0.24% | +40.2% |
| TPTX | Sell | TURNING POINT THERAPEUTICS INC | $10,515,000 | +26.7% | 86,294 | -9.1% | 0.24% | -16.3% |
| WSC | Sell | WILLSCOT MOBILE MINI HLDGS COR | $9,997,000 | -1.5% | 431,457 | -29.1% | 0.22% | -34.9% |
| PLUG | Sell | PLUG POWER | $9,101,000 | +114.0% | 268,380 | -15.4% | 0.20% | +41.7% |
| TCBI | Sell | TEXAS CAPITAL BANCSHARES | $8,890,000 | +77.7% | 149,410 | -7.0% | 0.20% | +17.6% |
| BLFS | Sell | BIOLIFE SOLUTIONS | $7,745,000 | +12.4% | 194,163 | -18.4% | 0.17% | -25.6% |
| VG | Sell | VONAGE HOLDINGS | $7,588,000 | -14.3% | 589,342 | -31.9% | 0.17% | -43.3% |
| XLRN | Sell | ACCELERON PHARMA | $7,481,000 | -42.9% | 58,474 | -49.8% | 0.17% | -62.2% |
| GTN | Sell | GRAY TELEVISION | $7,310,000 | +6.8% | 408,589 | -17.8% | 0.16% | -29.3% |
| RPD | Sell | RAPID7 | $7,119,000 | +38.3% | 78,959 | -6.1% | 0.16% | -8.6% |
| TTD | Sell | TRADE DESK INC CLASS A | $6,606,000 | -74.8% | 8,247 | -86.9% | 0.15% | -83.3% |
| HBIO | Sell | HARVARD BIOSCIENCE | $6,535,000 | +23.6% | 1,523,352 | -13.3% | 0.15% | -17.9% |
| PSTG | Sell | PURE STORAGE INC | $5,748,000 | -9.7% | 254,237 | -38.5% | 0.13% | -40.3% |
| IAC | Sell | IAC INTERACTIVECORP NEW | $5,359,000 | +26.6% | 28,300 | -19.9% | 0.12% | -16.7% |
| RGEN | Sell | REPLIGEN | $5,113,000 | -73.3% | 26,681 | -79.5% | 0.12% | -82.3% |
| KIDS | Sell | ORTHOPEDIATRICS | $5,062,000 | -16.2% | 122,714 | -6.7% | 0.11% | -44.4% |
| GAN | Sell | GAN LIMITED | $4,971,000 | -65.0% | 245,139 | -70.9% | 0.11% | -76.8% |
| TTGT | Sell | TECHTARGET INC | $4,794,000 | +16.0% | 81,098 | -13.8% | 0.11% | -22.9% |
| CYBR | Sell | CYBERARK SOFTWARE | $4,128,000 | +46.9% | 25,549 | -6.0% | 0.09% | -2.1% |
| AUTL | Sell | AUTOLUSadr | $4,164,000 | -39.8% | 465,795 | -21.6% | 0.09% | -60.4% |
| PRTK | Sell | PARATEK PHARMACEUTICALS | $3,607,000 | -3.1% | 576,122 | -16.3% | 0.08% | -35.7% |
| PTC | Sell | PTC INC | $3,579,000 | +40.7% | 29,921 | -2.7% | 0.08% | -7.0% |
| SAH | Sell | SONIC AUTOMOTIVE INC | $3,524,000 | -87.7% | 91,376 | -87.2% | 0.08% | -91.9% |
| NLTX | Sell | NEOLEUKIN THERAPEUTICS INC | $3,473,000 | -2.4% | 246,299 | -16.9% | 0.08% | -35.5% |
| KIN | Sell | KINDRED BIOSCIENCES | $3,245,000 | -15.9% | 752,822 | -16.3% | 0.07% | -44.3% |
| CTG | Sell | COMPUTER TASK GROUP | $3,209,000 | +11.7% | 524,373 | -9.3% | 0.07% | -26.5% |
| PRLB | Sell | PROTO LABS | $2,925,000 | +12.8% | 19,065 | -4.8% | 0.07% | -25.0% |
| FENC | Sell | FENNEC PHARMACEUTICALS | $2,941,000 | +12.5% | 394,810 | -8.5% | 0.07% | -25.8% |
| JNCE | Sell | JOUNCE THERAPEUTICS | $2,800,000 | -27.2% | 400,013 | -15.2% | 0.06% | -51.9% |
| TER | Sell | TERADYNE | $2,825,000 | +32.6% | 23,563 | -12.1% | 0.06% | -12.5% |
| ONTO | Sell | ONTO INNOVATION | $2,765,000 | -64.8% | 58,153 | -78.0% | 0.06% | -76.8% |
| BLUE | Sell | BLUEBIRD BIO INC | $2,600,000 | -49.2% | 60,085 | -36.6% | 0.06% | -66.7% |
| NEWR | Sell | NEW RELIC | $2,385,000 | +14.3% | 36,473 | -1.5% | 0.05% | -23.9% |
| XENE | Sell | XENON PHARMACEUTICALS | $2,358,000 | +34.2% | 153,321 | -3.4% | 0.05% | -11.7% |
| PCTY | Sell | PAYLOCITY HOLDINGS CORP | $2,171,000 | -92.2% | 10,544 | -93.9% | 0.05% | -94.8% |
| EXAS | Sell | EXACT SCIENCES | $2,103,000 | -54.4% | 15,876 | -64.9% | 0.05% | -70.1% |
| CTMX | Sell | CYTOMX THERAPEUTICS | $1,829,000 | -16.6% | 279,218 | -15.3% | 0.04% | -44.6% |
| XERS | Sell | XERIS PHARMACEUTICALS INC | $1,538,000 | -25.1% | 312,590 | -9.8% | 0.04% | -50.0% |
| ARGX | Sell | ARGENX SE ADRadr | $1,195,000 | -88.4% | 4,064 | -89.6% | 0.03% | -92.3% |
| CDTX | Sell | CIDARA THERAPEUTICS | $944,000 | -41.1% | 471,839 | -16.1% | 0.02% | -61.1% |
| OTIC | Sell | OTONOMY INC | $889,000 | +44.1% | 137,465 | -9.8% | 0.02% | -4.8% |
| Sell | DERMTECH INC | $541,000 | -19.5% | 16,679 | -70.3% | 0.01% | -47.8% | |
| MPAA | Sell | MOTOR PARTS OF AMERICA | $414,000 | -86.6% | 21,098 | -89.3% | 0.01% | -91.4% |
| PFIE | Exit | PROFIRE ENERGY | $0 | – | -288,453 | -100.0% | -0.01% | – |
| SOHO | Exit | SOTHERLY HOTELS | $0 | – | -135,552 | -100.0% | -0.01% | – |
| HZO | Exit | MARINEMAX INC | $0 | – | -10,057 | -100.0% | -0.01% | – |
| IR | Exit | INGERSOLL RAND INC | $0 | – | -16,993 | -100.0% | -0.02% | – |
| LSF | Exit | LAIRD SUPERFOOD | $0 | – | -15,689 | -100.0% | -0.02% | – |
| Exit | NABRIVA THERAPEUTICS PLC | $0 | – | -1,407,893 | -100.0% | -0.02% | – | |
| RMBL | Exit | RUMBLE ON INC CLASS B | $0 | – | -65,117 | -100.0% | -0.06% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS | $0 | – | -44,625 | -100.0% | -0.06% | – |
| QTS | Exit | QTS REALTY TRUST | $0 | – | -30,291 | -100.0% | -0.06% | – |
| IPHI | Exit | INPHI | $0 | – | -25,669 | -100.0% | -0.10% | – |
| AAN | Exit | AARON'S INC. | $0 | – | -119,477 | -100.0% | -0.23% | – |
| OXFD | Exit | OXFORD IMMUNOTEC GLOBAL PLC | $0 | – | -585,444 | -100.0% | -0.23% | – |
| GOCO | Exit | GOHEALTH CLASS A | $0 | – | -848,850 | -100.0% | -0.38% | – |
| VRTU | Exit | VIRTUSA CORP | $0 | – | -293,902 | -100.0% | -0.49% | – |
| QTWO | Exit | Q2 HOLDINGS | $0 | – | -162,620 | -100.0% | -0.50% | – |
| IMMU | Exit | IMMUNOMEDICS | $0 | – | -179,141 | -100.0% | -0.52% | – |
| UPLD | Exit | UPLAND SOFTWARE | $0 | – | -454,065 | -100.0% | -0.58% | – |
| DBX | Exit | DROPBOX INC | $0 | – | -992,272 | -100.0% | -0.65% | – |
| PTAC | Exit | PROPTECH ACQUISITION CORP | $0 | – | -2,911,332 | -100.0% | -1.10% | – |
| PS | Exit | PLURALSIGHT INC CLASS A | $0 | – | -1,969,192 | -100.0% | -1.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-12
Signatures
The EDGAR filing(s) were signed by:
About Granahan Investment Management
Granahan Investment Management is a Boston-based investment firm that specializes in small-cap growth equity strategies. The firm was founded in 1985 by Jane Granahan and her late husband, Gerald Granahan, who was a pioneer in the small-cap growth investing space. Today, the firm is led by CEO and Chief Investment Officer Gary Hatton, who has been with the firm since 1993.
Granahan Investment Management has a team of experienced investment professionals who conduct extensive research to identify high-growth companies with strong fundamentals and attractive valuations. The firm's investment process is focused on bottom-up stock selection, with a long-term investment horizon. The team seeks to invest in companies with sustainable competitive advantages, strong management teams, and attractive growth prospects.
The firm manages several mutual funds, including the Granahan Small Cap Advantage Fund, which has a 5-star Morningstar rating and has outperformed its benchmark over the long term. The firm also manages separate accounts for institutional clients.
Granahan Investment Management has a strong culture of integrity, teamwork, and client service. The firm's investment professionals are committed to delivering superior investment results and building long-term relationships with their clients.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| COSTAR GROUP INC | 42 | Q3 2023 | 4.7% |
| SPS COMM INC | 42 | Q3 2023 | 3.5% |
| EURONET WORLDWIDE, INC | 42 | Q3 2023 | 1.7% |
| OSI SYSTEMS INC | 42 | Q3 2023 | 2.4% |
| RBC BEARINGS INC | 42 | Q3 2023 | 1.5% |
| DOUGLAS DYNAMICS INC | 42 | Q3 2023 | 1.0% |
| PROS HOLDINGS INC | 42 | Q3 2023 | 0.8% |
| RADWARE LTD | 42 | Q3 2023 | 1.3% |
| RUSH ENTERPRISES INC | 42 | Q3 2023 | 1.1% |
| POWER INTEGRATIONS INC | 42 | Q3 2023 | 0.9% |
View Granahan Investment Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Evolent Health, Inc. | February 14, 2023 | 3,155,211 | 3.1% |
| SHOTSPOTTER, INC | February 14, 2023 | 552,625 | 4.5% |
| ALTA EQUIPMENT GROUP INC. | February 14, 2022 | 1,453,547 | 4.5% |
| CF Finance Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
| Cricut, Inc. | February 14, 2022 | 1,779,127 | 4.9% |
| NAUTILUS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| ONESPAWORLD HOLDINGS Ltd | February 14, 2022 | 2,978,807 | 4.0% |
| Victory Capital Holdings, Inc. | February 14, 2022 | 879,608 | 1.3% |
| dMY Technology Group, Inc. IISold out | May 11, 2021 | 0 | 0.0% |
| RumbleON, Inc. | January 21, 2021 | 40,877 | 1.9% |
View Granahan Investment Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-11 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Granahan Investment Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.